Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Trichorhinophalangeal syndrome type I - Clinical, microscopic, and molecular features

Authors
Jeon, JiehyunKim, Joo HaOh, Chil Hwan
Issue Date
1월-2014
Publisher
MEDKNOW PUBLICATIONS & MEDIA PVT LTD
Keywords
Autosomal dominant genetic disorder; trichorhinophalangeal syndrome; TRPS 1 gene
Citation
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, v.80, no.1, pp.54 - 57
Indexed
SCIE
SCOPUS
Journal Title
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY
Volume
80
Number
1
Start Page
54
End Page
57
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/99690
DOI
10.4103/0378-6323.125515
ISSN
0378-6323
Abstract
Trichorhinophalangeal syndrome type I (TRPS I) is an autosomal dominant malformation syndrome characterized by a triad of hair alteration, craniofacial and skeletal abnormalities. TRPS1 gene was first identified in 2000 and mapped on chromosome 8q23.3. A 39-year-old female patient with short stature (149 cm) visited for fine sparse and slow-growing hair with receded medio-occipital hairline of roughly triangular shape since infancy. A typical pear-shaped nose and elongated philtrum were noticeable. In addition, she reported deviation of middle phalanges, bilateral coxa varus in both hips and brachydactyly on bilateral fourth digits. Mutation analysis identified a transition of cytosine to thymine at position 1630 (exon 4), which results in amino acid change R544X and a premature stop of translation. There is no established treatment. But through careful evaluation of suspicious cases to identify potential mutation carriers, the patient can receive information about the disease and genetic counseling.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE